Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Abbott Laboratories (ABT) Insider Trading Activity
Healthcare • Medical Devices • 114,000 employees
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Total Value
-$20,971,306.37
Total Shares
-1,291
Average Trade Value
-$1,613,177.41
Most Active Insider
Allen Hubert L
Total Activity: $25,823,085
Largest Single Transaction
$17,578,702
by Allen Hubert L on Oct 21, 2024
30-Day Activity
0 Transactions
Volume: 0 shares
Value: $0
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
---|---|---|---|---|---|---|
Executive Vice President
|
Oct 21, 2024 | 150,271 | $17,578,702 | 184,806 (-81.3%) | Sale | |
Executive Vice President
|
Oct 21, 2024 | 5,901 | $697,203 | 335,077 (-1.8%) | Sale | |
Executive Vice President
|
Oct 21, 2024 | 157,421 | $7,398,787 | 342,227 (+46.0%) | Exercise/Conversion | |
Executive Vice President
|
Oct 21, 2024 | 1,249 | $148,394 | 340,978 (-0.4%) | Sale | |
Chairman and CEO
|
Sep 12, 2024 | 61,380 | $7,175,322 | 220,059 (-27.9%) | Sale | |
Chairman and CEO
|
Sep 12, 2024 | 14,243 | $696,483 | 361,738 (+3.9%) | Exercise/Conversion | |
Chairman and CEO
|
Sep 12, 2024 | 127,436 | $5,989,492 | 347,495 (+36.7%) | Exercise/Conversion | |
Chairman and CEO
|
Sep 12, 2024 | 80,299 | $9,317,896 | 281,439 (-28.5%) | Sale | |
Vice President
|
Sep 4, 2024 | 27 | $3,100 | 18,681 (-0.1%) | Sale | |
Executive Vice President
|
Sep 1, 2024 | 387 | $43,835 | 38,966 (-1.0%) | Payment of Exercise Price | |
Vice President
|
Sep 1, 2024 | 52 | $5,890 | 18,708 (-0.3%) | Payment of Exercise Price | |
Executive Vice President
|
Jul 1, 2024 | 556 | $57,774 | 62,143 (-0.9%) | Payment of Exercise Price | |
Executive Vice President
|
Jun 30, 2024 | 269 | $27,952 | 62,699 (-0.4%) | Payment of Exercise Price |